Carmat jumps after first implantation of its bioprosthetic artificial heart

PARIS (Reuters) – Carmat’s shares jumped on Tuesday after the French company announced the first implantation of its bioprosthetic artificial heart in a final-stage clinical trial.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *